Spots Global Cancer Trial Database for stage i pancreatic cancer
Every month we try and update this database with for stage i pancreatic cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer | NCT00002689 | Pancreatic Canc... | dexamethasone fluorouracil brachytherapy phosphorus P32 radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer | NCT00274885 | Cancer | oxaliplatin management of t... | 18 Years - | National Cancer Institute (NCI) | |
Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | NCT00003216 | Pancreatic Canc... | fluorouracil gemcitabine hyd... radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer | NCT00547612 | Pancreatic Canc... | high performanc... pharmacological... [18F]-labeled s... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer | NCT00389610 | Pancreatic Canc... | GVAX pancreas v... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer | NCT00003025 | Pancreatic Canc... | vitespen | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | NCT00058201 | Pancreatic Canc... | fluorouracil gemcitabine hyd... leucovorin calc... clinical observ... | 18 Years - | National Cancer Institute (NCI) | |
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer | NCT01959672 | Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | 4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con... | 19 Years - | University of Nebraska | |
Chemoradiation in Locally Advanced Pancreatic Cancer | NCT00262951 | Pancreatic Canc... | recombinant int... cisplatin fluorouracil radiation thera... Resection of tu... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | NCT00004895 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine... | octreotide acet... | 18 Years - | Northwestern University | |
Individualized Drug Treatment for Treating Patients With Pancreatic Cancer | NCT00276744 | Pancreatic Canc... | cetuximab capecitabine docetaxel Erlotinib Gemcitabine Irinotecan mitomycin C rapamycin conventional su... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer | NCT00068575 | Pancreatic Canc... | Recombinant Int... Cisplatin Fluorouracil Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA) | NCT00313560 | Pancreatic Canc... | erlotinib hydro... | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | NCT00544193 | Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera... | 18 Years - 70 Years | City of Hope Medical Center | |
Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer | NCT00003025 | Pancreatic Canc... | vitespen | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders | NCT00830557 | Islet Cell Tumo... Pancreatic Canc... Pancreatic Dise... | medical chart r... survey administ... biospecimen col... | 18 Years - 120 Years | Mayo Clinic | |
Pancreatic Cancer Collaborative Registry | NCT00661882 | Pancreatic Canc... | medical chart r... questionnaire a... study of socioe... biopsy | 19 Years - 100 Years | University of Nebraska | |
Individualized Drug Treatment for Treating Patients With Pancreatic Cancer | NCT00276744 | Pancreatic Canc... | cetuximab capecitabine docetaxel Erlotinib Gemcitabine Irinotecan mitomycin C rapamycin conventional su... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery | NCT00524069 | Pancreatic Canc... | bevacizumab capecitabine gemcitabine hyd... flow cytometry laboratory biom... adjuvant therap... computed tomogr... neoadjuvant the... | 18 Years - | Roswell Park Cancer Institute | |
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | NCT00436410 | Adrenocortical ... Breast Cancer Colorectal Canc... Gastrointestina... Kidney Cancer Liver Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Sarcoma | colloidal gold-... electron micros... pharmacological... conventional su... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder | NCT00489515 | Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | 18 Years - 120 Years | Wake Forest University Health Sciences | ||
Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | NCT00003216 | Pancreatic Canc... | fluorouracil gemcitabine hyd... radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer | NCT01959672 | Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | 4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con... | 19 Years - | University of Nebraska | |
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer | NCT00087191 | Advanced Adult ... Carcinoma of th... Fallopian Tube ... Gastrointestina... Localized Extra... Localized Gallb... Localized Gastr... Localized Resec... Localized Unres... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Primary Periton... Recurrent Adult... Recurrent Adult... Recurrent Colon... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Small... Recurrent Uteri... Regional Gastro... Small Intestine... Small Intestine... Small Intestine... Stage 0 Non-sma... Stage I Adult S... Stage I Colon C... Stage I Gastric... Stage I Non-sma... Stage I Ovarian... Stage I Ovarian... Stage I Pancrea... Stage I Rectal ... Stage I Uterine... Stage II Adult ... Stage II Colon ... Stage II Gastri... Stage II Non-sm... Stage II Ovaria... Stage II Ovaria... Stage II Pancre... Stage II Rectal... Stage II Uterin... Stage III Adult... Stage III Colon... Stage III Gastr... Stage III Ovari... Stage III Ovari... Stage III Pancr... Stage III Recta... Stage III Uteri... Stage IIIA Non-... Stage IIIB Non-... Stage IV Adult ... Stage IV Colon ... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Stage IV Uterin... Unresectable Ex... Unresectable Ga... | EF5 motexafin lutet... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic Cancer | NCT00460174 | Pancreatic Canc... | bevacizumab gemcitabine conventional su... radiation thera... | 18 Years - 120 Years | Northwestern University | |
Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas | NCT00003049 | Pancreatic Canc... | fluorouracil leucovorin calc... conventional su... radiation thera... | 18 Years - 120 Years | Mayo Clinic | |
Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas | NCT00084383 | Pancreatic Canc... | GVAX pancreatic... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | NCT00058201 | Pancreatic Canc... | fluorouracil gemcitabine hyd... leucovorin calc... clinical observ... | 18 Years - | National Cancer Institute (NCI) | |
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen | NCT00016380 | Cancer | dexamethasone ondansetron quality-of-life... | 16 Years - 120 Years | Canadian Cancer Trials Group | |
Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer | NCT00003085 | Pancreatic Canc... | laparoscopy ultrasound imag... | 18 Years - | University of Southern California | |
Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | NCT00882765 | Pancreatic Canc... | genistein | 18 Years - | Jonsson Comprehensive Cancer Center | |
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer | NCT01959672 | Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | 4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con... | 19 Years - | University of Nebraska | |
Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas | NCT00003049 | Pancreatic Canc... | fluorouracil leucovorin calc... conventional su... radiation thera... | 18 Years - 120 Years | Mayo Clinic | |
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer | NCT00003546 | Pancreatic Canc... | gemcitabine hyd... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | NCT00004895 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine... | octreotide acet... | 18 Years - | Northwestern University | |
Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer | NCT00059826 | Pancreatic Canc... | interferon-alfa... cisplatin 5-fluorouracil radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders | NCT00830557 | Islet Cell Tumo... Pancreatic Canc... Pancreatic Dise... | medical chart r... survey administ... biospecimen col... | 18 Years - 120 Years | Mayo Clinic | |
Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | NCT00733746 | Pancreatic Canc... | erlotinib hydro... gemcitabine hyd... therapeutic con... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Biological Markers in Patients With Pancreatic Cancer Experiencing Weight Loss | NCT00899158 | Cachexia Pancreatic Canc... | immunologic tec... laboratory biom... biopsy | 18 Years - | Case Comprehensive Cancer Center | |
Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas | NCT00010166 | Pancreatic Canc... | gemcitabine hyd... adjuvant therap... radiation thera... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer | NCT00983268 | Pancreatic Canc... Periampullary A... | capecitabine vorinostat Radiotherapy Surgery to remo... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer | NCT00983268 | Pancreatic Canc... Periampullary A... | capecitabine vorinostat Radiotherapy Surgery to remo... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
Studying Biomarkers in Patients With Pancreatic Cancer | NCT00900003 | Pancreatic Canc... | protein analysi... laboratory biom... | - | Vanderbilt-Ingram Cancer Center | |
Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer | NCT00002689 | Pancreatic Canc... | dexamethasone fluorouracil brachytherapy phosphorus P32 radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | NCT00733746 | Pancreatic Canc... | erlotinib hydro... gemcitabine hyd... therapeutic con... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas | NCT00003923 | Extrahepatic Bi... Gallbladder Can... Liver Cancer Pancreatic Canc... | porfimer sodium | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | NCT00544193 | Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera... | 18 Years - 70 Years | City of Hope Medical Center | |
Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer | NCT00010062 | Pancreatic Canc... | fluorouracil radiation thera... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer | NCT00064207 | Pancreatic Canc... | gemcitabine hyd... adjuvant therap... radiation thera... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen | NCT00016380 | Cancer | dexamethasone ondansetron quality-of-life... | 16 Years - 120 Years | Canadian Cancer Trials Group | |
Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | NCT00733746 | Pancreatic Canc... | erlotinib hydro... gemcitabine hyd... therapeutic con... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Margin-Intense Combo Therapy in Pts w/Potentially Resectable Pancreatic Cancer | NCT01025882 | Pancreatic Canc... | gemcitabine hyd... stereotactic bo... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery | NCT00727441 | Pancreatic Canc... | GVAX pancreatic... cyclophosphamid... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer | NCT00389610 | Pancreatic Canc... | GVAX pancreas v... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction | NCT00004910 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Gastrointestina... Pancreatic Canc... Quality of Life Small Intestine... | bowel obstructi... quality-of-life... | 18 Years - | Northwestern University | |
Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer | NCT00253526 | Adenocarcinoma ... Recurrent Pancr... Stage I Pancrea... Stage II Pancre... Stage III Pancr... | bevacizumab gemcitabine hyd... adjuvant therap... anti-cytokine t... antiangiogenesi... antibody therap... biological ther... chemotherapy conventional su... growth factor a... monoclonal anti... surgery | 18 Years - | National Cancer Institute (NCI) | |
Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer | NCT02047474 | Acinar Cell Ade... Duct Cell Adeno... Stage I Pancrea... Stage IIA Pancr... Stage IIB Pancr... | oxaliplatin leucovorin calc... irinotecan hydr... fluorouracil therapeutic con... laboratory biom... | 18 Years - | Yale University | |
Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer | NCT01150630 | Pancreatic Canc... | capecitabine cisplatin epirubicin gemcitabine | 18 Years - 75 Years | IRCCS San Raffaele | |
Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer | NCT00983268 | Pancreatic Canc... Periampullary A... | capecitabine vorinostat Radiotherapy Surgery to remo... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants | NCT00898482 | Pancreatic Canc... | This is a non-i... study of socioe... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Studying Biomarkers in Patients With Pancreatic Cancer | NCT00900003 | Pancreatic Canc... | protein analysi... laboratory biom... | - | Vanderbilt-Ingram Cancer Center | |
Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery | NCT00410774 | Pancreatic Canc... | bevacizumab gemcitabine hyd... adjuvant therap... | 18 Years - | University of California, San Francisco | |
Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | NCT00058201 | Pancreatic Canc... | fluorouracil gemcitabine hyd... leucovorin calc... clinical observ... | 18 Years - | National Cancer Institute (NCI) | |
Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer | NCT00003591 | Pancreatic Canc... | paclitaxel radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer | NCT00010062 | Pancreatic Canc... | fluorouracil radiation thera... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer | NCT00003434 | Pancreatic Canc... | carcinoembryoni... hepatitis B ant... | 18 Years - | Duke University |